December 12, 2013 at 15:23 PM EST
U.S. FDA warns against nipple test for breast cancer
Dec 12 (Reuters) - A nipple fluid test is not an effective screening tool for breast cancer, U.S. regulators warned on Thursday, noting that mammography is the best way to detect the disease in its earliest, most treatable stages.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here